Johnson & Johnson Earnings Expected Tuesday

robot
Abstract generation in progress

Johnson & Johnson (JNJ) is set to release its Q1 2026 earnings report on Tuesday, April 14, with analysts forecasting earnings of $2.68 per share and revenue of $23.6038 billion. The healthcare giant’s performance is closely watched as a benchmark for the pharmaceutical and medical device industries. Investors and analysts will monitor the earnings call for insights into the company’s financial health, product pipeline, and future outlook.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin